We developed an immunoprecipitation-RNA-random PCR (rPCR) method to isolate cellular RNA sequences that bind to the folate-dependent enzyme thymidylate synthase (TS). Using this approach, nine different cellular RNAs that formed a ribonucleoprotein ( 
INTRODUCTION
Thymidylate synthase (TS) is a folate-dependent enzyme that catalyzes the reductive methylation of 2′-deoxyuridine-5′-monophosphate by the reduced folate 5,10-methylenetetrahydrofolate to form thymidylate (1) . Given that the TS-catalyzed enzymatic reaction provides the sole intracellular de novo source of thymidylate, an essential precursor for DNA biosynthesis, this enzyme is an important target for cancer chemotherapy (2, 3) .
Although its critical role in catalysis and cellular metabolism has been well characterized, it is now appreciated that TS also functions as an RNA binding protein (4, 5) . Experiments using an in vitro translation system (rabbit reticulocyte lysate) revealed that translation of human TS mRNA is controlled by its own protein product via a negative autoregulatory mechanism. The translational repression of TS mRNA is mediated by specific binding of TS to two different cis-acting elements on its own mRNA. The first site is contained within the first 188 nt of the mRNA and includes the translational start site in a putative stem-loop structure, while the second site is located within a 200 nt sequence in the protein coding region (5) . Recent work has revealed that the interaction between TS and its target TS mRNA is exquisitely sensitive to the redox state of the protein and is mediated by a reversible but complicated sulfhydryl switch mechanism (6) , an observation that also holds true for a number of other RNA binding proteins (7) (8) (9) (10) .
Further evidence to support the specific interaction between TS and its own mRNA comes from studies identifying a TS ribonucleoprotein (RNP) complex in cultured H630 human colon cancer cells (11) . This complex consists of TS protein bound to its own mRNA. In addition to interacting with its own mRNA, TS forms an RNP complex both in vivo and in vitro with the mRNA of the transcription factor c-myc (11, 12) . The specific cis-acting sequence to which TS protein binds has been localized to the C-terminal coding region. Additional studies using the rabbit reticulocyte translation system demonstrated that binding of TS protein to c-myc mRNA resulted in translational repression (12) . These findings, taken together, suggest that TS may be involved in the regulation of not only its own biosynthesis but also that of the unrelated c-myc gene.
There is now increasing evidence in the literature demonstrating the binding of regulatory proteins to various target DNA sequences (13) (14) (15) (16) (17) (18) (19) . In contrast, relatively little work has been done to identify RNA sequences that bind to cellular proteins in intact cells. Given our recent results on the high affinity binding of the mRNAs of TS and c-myc to TS protein, we investigated the potential for TS, as an RNA binding protein, to interact with other cellular RNAs. An immunoprecipitation-RNA-random PCR (RNA-rPCR) method was developed to purify human cellular RNA sequences bound to TS from actively growing cells. This approach has led to the identification of nine RNA sequences. The specificity of each of these RNA-TS protein interactions was investigated by cell-free RNA binding experiments and the results confirmed that seven of the nine newly identified RNAs bind TS with relatively high affinity (IC 50 values 1.5-6 nM). These initial findings suggest that the immunoprecipitation-Nucleic Acids Research, 1996, Vol. 24, No. 16 3223 RNA-rPCR method can be used to identify target RNA species that bind TS and that such an approach may begin to define those genes whose expression may be under some regulatory control by TS.
MATERIALS AND METHODS

Cell culture
The H630 human colon cancer cell line and its 5-fluorouracilresistant H630-R10 subline have been previously described (11, 20) . Cell lines were grown in 75 cm 2 plastic tissue culture flasks (Falcon Labware, Oxnard, CA) in RPMI 1640 growth medium containing 10% dialyzed fetal bovine serum and 2 mM glutamine. Dialyzed fetal bovine serum and all other tissue culture reagents were obtained from Gibco BRL (Grand Island, NY).
Whole cell extraction and immunoprecipitation of TS RNP complexes
Immunoprecipitation of TS RNP complexes was performed as described by Steitz (21, 22) . In brief, extracts from ∼5 × 10 8 cells were initially pre-cleared by incubation with pre-immune serum (350 µl) for 30 min on ice. The cleared extract was then incubated with TS polyclonal antibody (350 µl) for 30 min on ice to which Immunoprecipitin (150 µl; Gibco BRL), 35 µg yeast carrier RNA (US Biochemical, Cleveland, OH) and 30 U inhibitase (5-Prime, 3-Prime, Boulder, CO) were added for an additional 30 min.
Immunoprecipitates were centrifuged at 14 000 g for 3 min and then washed five times with 300 µl NET-2 buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl and 0.05% v/v Nonidet P-40). After addition of 300 µl NET-2 buffer, the pellets were subjected to phenol/chloroform extraction. The supernatant containing the nucleic acid was treated with 10 U RQ DNase (Promega, Madison, WI) for 15 min at 37_C. RNA was then extracted with phenol/chloroform (1:1), chloroform/isoamyl alcohol (24:1) and precipitated with 2.5 vol ethanol in the presence of 0.3 M sodium acetate (5-Prime, 3-Prime) and 20 µg glycogen (Boehringer Mannheim).
Reverse transcription (RT)-random PCR (rPCR) analysis
Immunoprecipitated RNA was subjected to reverse transcription in a reaction (50 µl) containing 50 mM Tris-HCl, pH 8.3, 10 mM DTT, 3 mM MgCl 2 , 500 µM each dNTP, 1 U RNase Block I (Stratagene), 50 U StrataScript reverse transcriptase (Stratagene) and 150 ng of either the universal primer dN6
The reaction conditions were as previously described by Froussard (23) except for the modifications as outlined below. In brief, the RT reaction was performed at 42_C for 1 h, after which the sample was heated to 95_C for 3 min and then cooled rapidly on ice. RNase H (0.5 µl; Gibco BRL) was added and the reaction mix was incubated at 37_C for 15 min. The sample was then heated to 95_C for 3 min and cooled on ice. Synthesis of the cDNA was then performed using Klenow fragment of DNA polymerase I. After incubation at 37_C for 30 min, the sample was purified on a G-50 D-RF column (5-Prime, 3-Prime) to eliminate excess universal primer dN6. Double-stranded cDNA was then used as template for rPCR amplification. The reagents used were those outlined by the Perkin-Elmer protocol (Perkin-Elmer, Foster City, CA) and included 1.5 mM MgCl 2 . The total volume of the reaction was 100 µl. Amplification was performed using 100 pmol of either the universal primer 5′-d(GCCGCTCGAGTGCAGAATTC)-3′ or the modified universal primer 5′-d(GCCGGAATTCTGCAGAAT-TC)-3′. The samples were incubated at 94_C for 1 min, 55_C for 1 min, 72_C for 3 min and amplified for 40 cycles. Following this initial PCR step, a chase reaction was performed according to previously published methods to ensure the synthesis of intact double-stranded cDNA (24) . Amplified, selected cDNA products were resolved on a 1% non-denaturing agarose gel.
To verify the presence of TS, c-myc and IFN-induced 15 kDa sequences in the amplified selected cDNA, PCR reactions were performed using 100 pmol of each of the following primer sets:
Reactions were incubated as previously described (11, 12) at 97_C for 1 min, 62_C for 1 min, 72_C for 1 min and amplified for 40 cycles. At the end of the last cycle, the reactions were incubated for an additional 10 min at 72_C then cooled to 4_C. PCR reactions were also performed with 30 and 35 cycles of amplification and identical results, as observed for the 40 cycle reaction, were obtained.
Library construction and screening
The cDNA products were purified using the Promega PCR Prep kit (Promega, Madison, WI) and digested with XhoI. For construction of the plasmid library, 1-5 ng XhoI-digested amplified cDNA was ligated to 100 ng XhoI-digested, dephosphorylated pGEM-7Z plasmid (Promega) and the recombinant plasmid was used to transform JM109 cells, which were grown overnight on ampicillin LB agar plates. Colonies were lifted onto nitrocellulose filters (25) which were then hybridized to an [α-32 P]dCTP-labeled probe representative of the cDNA used in construction of the library (26) . To confirm the presence of an insert in all positive clones, a colony PCR method employing SP6 and T7 promoter primers was used (27) .
For construction of the phage library, 1-5 ng EcoRI-digested amplified cDNA was ligated to 100 ng EcoRI-digested, dephosphoryated Uni-Zap II vector (Stratagene, La Jolla, CA) and the phage packaged using the Gigapack II Gold packaging extract (Stratagene). Plaques were lifted onto nitrocellulose filters (26) and the filters subsequently hybridized to an [α-32 P]dCTPlabeled c-myc fragment corresponding to the protein coding region or to an [α-32 P]dCTP-labeled full-length TS cDNA (26) . To confirm the presence of insert-containing phages, a colony PCR assay (27) was employed.
Plasmid preparation and in vitro mRNA transcription
Double-stranded DNA prepared from positive clones was sequenced by the fmol DNA sequencing system (Promega) using either the T7 or the SP6 promoter primer. DNA from selected clones was linearized with either HindIII or XbaI and transcribed in vitro with T7 RNA polymerase or with SP6 RNA polymerase to generate the corresponding mRNA transcript. All in vitro transcription reactions were performed as previously described (4, 5, 28) . Labeled RNAs were synthesized by inclusion of [α-32 P]CTP at 200 Ci/mmol in the reaction mixture. RNA products were analyzed on 1% agarose-formaldehyde gel to verify their integrity and size. The concentration of unlabeled RNA was determined by measuring UV absorbance at 260 nm, while the concentration of radioactively labeled RNAs was determined by the specific activity.
RNA-protein binding assay
RNA electrophoretic gel mobility shift assays (EMSAs) were performed as previously described (4, 5, 28) . In brief, radiolabeled RNAs (2 fmol, 100 000 c.p.m.) were incubated with TS protein (3 pmol) for 15 min at room temperature in a reaction mixture containing 10 mM HEPES, pH 7.4, 40 mM KCl, 3 mM MgCl 2 , 3 U inhibitase (5-Prime, 3-Prime), 250 mM 2-mercaptoethanol and 5% glycerol. RNase T1 (12 U; 5-Prime, 3-Prime) was then added for 10 min followed by 5 mg/ml heparin (Sigma, St Louis, MO) for an additional 10 min at room temperature. The entire reaction mix (total volume 30 µl) was resolved on a 4% non-denaturing polyacrylamide gel (acrylamide/methylenebisacrylamide 60:1) for ∼40 min at 500 V. The gel was dried and the bands visualized by autoradiography.
Competition experiments were performed with blue-dye Sepharose-purified human recombinant TS protein (3 pmol, specific activity 0.05 U/mg) (4) and radiolabeled TS mRNA (2 fmol, 100 000 c.p.m.). These conditions were selected on the basis of control experiments using a fixed amount of radiolabeled RNA probe with increasing TS protein concentration to determine the linearity of protein binding. Unlabeled competitor RNAs were mixed with radiolabeled TS mRNA probe prior to addition of TS protein. The relative binding affinity (IC 50 ) of each selected RNA was established by determining the concentration at which unlabeled RNA inhibits specific binding of radiolabeled TS mRNA by 50%. Each RNA competition experiment was performed three to four times. Quantitation by densitometry was done using a ScanJet Plus scanner (Hewlett Packard) and the results analyzed by the NIH Image 1.36 software (Wayne Rasband, National Institute of Mental Health, Bethesda, MD).
Western immunoblot analysis
H630 cells were harvested and processed as previously described (29) . Protein concentrations were determined by the BioRad protein assay and equivalent amounts of protein (250 µg) from each cell line were resolved by 15% SDS-PAGE according to the method of Laemmli (30) . The gels were then electroblotted onto Schleicher & Schuell nitrocellulose membranes. Primary antibody staining was performed by incubating filter membranes (overnight at 4_C) with either an anti-TS monoclonal antibody (1/100 dilution) (20) or an anti-ubiquitin cross-reactive protein (URCP) polyclonal antibody (10 µg/ml) (31) that recognizes the interferon (IFN)-induced 15 kDa protein. The membranes were subsequently incubated with horseradish peroxidase-conjugated secondary antibody (1/500 dilution; BioRad) for an additional 2 h (room temperature) and processed by the ECL chemiluminescent method (Amersham Life Science, Little Chalfont, UK). Protein bands were visualized by autoradiography. 
Isolation and analysis of total RNA
H630 cells were harvested and total RNA was isolated according to methods previously described (29) . After extraction, an aliquot of 25 µg total cellular RNA was denatured, resolved on 1% formaldehyde-agarose gel and transferred onto a Nytran filter membrane. The membrane was hybridized to an [α-32 P]dCTPlabeled DNA insert encoding the IFN-induced 15 kDa protein.
The membrane was then processed as previously described (29) .
RESULTS AND DISCUSSION
While the characterization of DNA-protein interactions by means of immunopurification of DNA-protein complexes has been well described (15) (16) (17) (18) (19) , significantly less work has been done to isolate RNA-protein complexes either in vitro or in vivo. Previous studies by Steitz and colleagues employed an immunoprecipitation method to isolate small nuclear RNAs (snRNAs) (21, 22) . Using this same technique, we attempted to identify TS RNP complexes from human colon cancer cells. However, these initial efforts were unsuccessful, presumably due to the relatively low level of expression of TS mRNA, ∼1000 molecules/cell, when compared with the relatively high level of expression of the various snRNAs, ∼10 5 -10 6 molecules/cell.
To determine the range of cellular mRNA species that directly interact with TS in intact cells, we developed the immunoprecipitation-RNA-rPCR method. The general scheme of this approach is outlined in Figure 1 . TS RNP complexes were immunoprecipitated from human colon cancer H630-R10 cells using an anti-TS polyclonal antibody. The TS-bound nucleic acid was isolated by standard phenol/chloroform extraction and then treated with RNase-free DNase to remove contaminating DNA. 1-3) or with pre-immune antiserum (lane 4), treated in the absence (lane 1) or presence (lane 3) of MMLTV reverse transcriptase and PCR amplified using the universal primer as described in Materials and Methods. In lane 2, the immunoprecipitated nucleic acid was treated with RNase A prior to the reverse transcription step. The PCR-amplified cDNA products were resolved on a 1% agarose gel stained with ethidium bromide. The migration of free primers is indicated by the arrow.
Since the sequences of the immunoprecipitated RNAs are unknown, a 26 nt primer containing a random hexamer at its 3′-end was employed for synthesis of the first and second cDNA strands. Amplification of the resulting cDNA was performed with a 20 nt universal primer. The cDNA products were subsequently digested with the restriction enzyme XhoI and cloned into pGEM-7Z plasmid.
The application of such an approach for isolating cellular RNA sequences bound to TS in vivo is presented in Figure 2 . Immunoprecipitation of H630-R10 extracts with a polyclonal anti-TS antibody followed by rPCR amplification with a 20 nt universal primer gave rise to a population of cDNA products, termed amplified selected cDNAs, ranging in size from 0.1 to 1.2 kb (Fig. 2, lane 3) . To verify that the cDNA bound to TS in RNP complexes was indeed a copy of cellular RNA species, various control experiments were performed in which cellular RNAs immunoprecipitated with TS polyclonal antibody were either directly PCR amplified without reverse transcription (Fig. 2 , lane 1) or were treated with RNase A prior to the step of reverse transcription (Fig. 2, lane 2) . Amplified cDNA products were not detected in either case. The specificity of the immunoprecipitation reaction was confirmed when neither an unrelated antibody, such as pre-immune antiserum (Fig. 2, lane 4) , nor the absence of an antibody (data not shown) failed to give rise to any cDNA products.
Following cloning of the amplified selected cDNAs into the pGEM-7Z plasmid, insert-containing clones were identified by hybridization with an [α-32 P]-labeled probe generated from the selected cDNAs. Positive clones were then subjected to either the colony PCR method using SP6 and T7 promoter primers (27) or to digestion with XhoI restriction endonuclease to verify the presence of an insert. Using this approach, nine clones were isolated and sequenced. The DNA inserts ranged in size from 54 to 122 bp (Table 1) . A search of the gene database revealed that each of these DNAs contained homology to a sequence previously described (Tables 1 and 2 ). However, no significant sequence homology was detected among these sequences.
The corresponding cRNAs for the nine inserts were subsequently synthesized in vitro. The relative binding affinities of these RNA species to TS were then determined using the RNA gel shift competition assay. Previous studies showed that TS binds with relatively high affinity to its own mRNA (IC 50 1 nM) as well as to c-myc mRNA (IC 50 1.5 nM). Seven of nine RNA sequences bound to TS protein with relatively high affinity, with IC 50 values ranging from 1.5 to 6.0 nM (Table 1) . RNA sequences with high similarity to the human p53 gene (IC 50 1.5 nM) and the gene encoding human IFN-induced 15 kDa protein (IC 50 1.6 nM) respectively bound TS with an affinity nearly identical to that previously reported for the human TS mRNA (IC 50 1 nM). Five other RNA sequences with high similarity to the human gene for small cytoplasmic 7S RNA, human zinc finger protein 8 gene, Aspergillus niger zinc finger protein gene, human kinesin heavy chain gene and human mitochondrial complete gene also bound TS with relatively high affinity. Two sequences corresponding to 18S and 28S rRNA were also found to form RNP complexes with TS. However, in contrast to the other RNA species, competition analysis revealed that each of these rRNAs bound TS with significantly lower affinity (IC 50 >50 nM), suggesting that they may have been immunoprecipitated as part of a polysome complex with TS. Nucleotides with no identity to the known genomic sequence are underlined and in bold.
To investigate the potential biological relevance of TS-bound RNA sequences, we immunoprecipitated TS RNP complexes from H630-R10 cells, isolated the RNA fraction bound to TS and performed RT-PCR amplification using primers specific for the IFN-induced 15 kDa gene. This immunoprecipitation gave rise to a 123 nt RNA fragment (Fig. 3, lane 5) . In contrast, no detectable level of IFN-induced 15 kDa mRNA was complexed to TS in H630 cells that express ∼20-fold less TS protein (Fig. 3, lane 4) . The specificity of antibody recognition was confirmed by using pre-immune antiserum in the immunoprecipitation reaction and no DNA product was amplified (Fig. 3, lane 6 ). As controls, we performed the following: (i) the immunoprecipitated nucleic acid was treated with RNase prior to RT-PCR amplification (Fig. 3, lane  7) ; (ii) the immunoprecipitated nucleic acid fraction was subjected to direct PCR amplification (Fig. 3, lane 8) . In neither case was an amplified cDNA product detected. Although the level of IFNinduced 15 kDa mRNA bound to TS protein in the form of a RNP complex was significantly higher in TS-overexpressing H630-R10 cells, the level of mRNA expression in both cell lines (H630 and H630-R10) was nearly the same, as determined by RT-PCR (Fig.  3, lanes 2 and 3) and by Northern blot analysis (Fig. 4C) .
To determine the potential biological effect of the binding of TS protein to the IFN-induced 15 kDa mRNA, the level of expression of the 15 kDa protein product in H630 and H630-R10 cells was determined. A striking inverse relationship was observed between the level of expression of TS and the 15 kDa protein (Fig. 4) . In H630-R10 cells expressing 20-fold higher levels of TS relative to their H630 parental cells, significantly lower levels (7-fold) of the 15 kDa protein were observed (Fig. 4) . To lend further support to (Fig. 4A ) and the level of expression of the 15 kDa protein in the H630-R10rev cells was restored to a level approaching that observed in H630 cells (Fig. 4B) . Since the level of expression of the mRNA for the 15 kDa protein was nearly the same in parent H630, resistant H630-R10 and revertant H630-R10 cells (Fig. 4C) , these findings suggest that synthesis of the 15 kDa IFN-induced protein is controlled, in part, at the translational level. Furthermore, expression of 15 kDa protein in cells overexpressing TS may be regulated via direct binding of TS to the 15 kDa mRNA.
In this manuscript, we employed an immunoprecipitation-RNA-rPCR method to identify cellular RNA sequences that bind to TS in intact cells. This new approach has several important advantages over previously developed methods. First, using the rPCR step, picomole amounts of immunoprecipitated RNA can be amplified and employed. Second, the effects of efficiency of recovery at each step is greatly minimized by inclusion of the amplification reaction. As a result, the selection process can be designed to allow for maximal stringency. Third, the use of universal random primers in both the reverse transcription and PCR amplification steps readily allows for the isolation of TS-bound cellular mRNAs whose sequences are unknown. This is in marked contrast to the immunoprecipitation-RT-PCR method, where sequences of the bound mRNAs are already known, thereby requiring gene-specific primers to be employed in the amplification reaction. Fourth, the amplified selected cDNAs can be cloned directly into either a plasmid or phage vector and, finally, the relative binding affinities of RNA to TS protein can be rapidly determined by RNA gel shift competition assays.
In the present report, a plasmid cDNA library was constructed to isolate novel RNA sequences that interact with TS. Of note, a Uni-Zap phage library was also constructed. Previous studies have shown that TS RNP complexes contain both TS and c-myc mRNAs. Although these mRNAs were not present in the plasmid library, they were detected in the λ cDNA library (data not shown), demonstrating that this library contains a more complete representation of the cellular RNAs that form RNP complexes with TS.
Recent studies have demonstrated that RNA binding proteins can interact with more than one RNA species (32) (33) (34) (35) (36) (37) . The results presented herein support this concept. Comparative analysis of the nine sequences isolated from the plasmid library with those of TS and c-Myc have failed, thus far, to identify a consensus nucleotide binding sequence. One potential drawback of employing such a 'consensus' approach is that most RNA binding proteins characterized to date appear to recognize a combination of structure and sequence.
The seven newly isolated cellular RNAs that form RNP complexes with TS are noteworthy, since several of them display homology to genes encoding the human p53 protein, IFNinduced 15 kDa protein and human zinc finger protein 8, all of which have been implicated as playing a role in cellular growth and metabolism. Both p53 and c-myc encode nuclear phosphoproteins that play critical roles in the regulation of cell cycle progression, DNA synthesis and apoptosis (38) (39) (40) (41) (42) (43) (44) (45) . Recent studies from this laboratory confirmed that human recombinant TS specifically binds to a 489 nt sequence in the protein coding region of the human p53 mRNA. Furthermore, this interaction results in the repression of p53 mRNA translation (46) . Our recent studies have also shown that TS specifically interacts with the mRNA of the transcription factor c-myc (11, 12) . Although the binding of TS to 28S and 18S rRNA may only result from a physical interaction at the level of the polysome, it is possible that the interaction with these cytoplasmic rRNAs, albeit weak, may also play some role in the overall control of translation within the cell. Thus, TS may be involved in the coordinate regulation of expression and/or function of various cellular genes and it may play an important role as a regulator of certain critical aspects of cellular metabolism.
These studies contribute to our understanding of the complex interactions between TS and cellular RNAs and they underscore the concept that the mechanisms that underlie the regulation of cellular gene expression are highly complex events. Finally, the general strategy employed herein may be directly applicable for the identification and isolation of in vivo target RNA sequences of other RNA binding proteins.
